![]()
|
|
||||||||
J. Biol. Chem., Vol. 278, Issue 5, 2837-2844, January 31, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Cytochrome P450c17 catalyzes
17
Protein Phosphatase 2A and Phosphoprotein SET Regulate Androgen
Production by P450c17*
,
¶
Department of Pediatrics and
§ Department of Obstetrics, Gynecology, and Reproductive
Sciences, the ¶ Metabolic Research Unit and the Center for
Reproductive Sciences, University of California,
San Francisco, California 94143-0978
-hydroxylation needed for cortisol synthesis and 17,20 lyase
activity needed to produce sex steroids. Serine phosphorylation of
P450c17 specifically increases 17,20 lyase activity, but the
physiological factors regulating this effect remain unknown. Treating
human adrenal NCI-H295A cells with the phosphatase inhibitors okadaic
acid, fostriecin, and cantharidin increased 17,20 lyase activity,
suggesting involvement of protein phosphatase 2A (PP2A) or 4 (PP4).
PP2A but not PP4 inhibited 17,20 lyase activity in microsomes from
cultured cells, but neither affected 17
-hydroxylation. Inhibition of
17,20 lyase activity by PP2A was concentration-dependent,
could be inhibited by okadaic acid, and was restored by endogenous
protein kinases. PP2A but not PP4 coimmunoprecipitated with P450c17,
and suppression of PP2A by small interfering RNA increased 17,20 lyase
activity. Phosphoprotein SET found in adrenals inhibited PP2A, but not
PP4, and fostered 17,20 lyase activity. The identification of PP2A and
SET as post-translational regulators of androgen biosynthesis suggests
potential additional mechanisms contributing to adrenarche and
hyperandrogenic disorders such as polycystic ovary syndrome.
*
This work was supported by National Institutes of Health
Grants HD34449 (to W. L. M.), HD41958 (to W. L. M.), and HD27970 (to S. H. M.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of
Pediatrics, Bldg. MR4, Rm. 209, University of California, San
Francisco, CA 94143-0978. Tel.: 415-476-2598; Fax: 415-476-6286;
E-mail: wlmlab@itsa.ucsf.edu.
This article has been cited by other articles:
![]() |
E. Hershkovitz, R. Parvari, S. A. Wudy, M. F. Hartmann, L. G. Gomes, N. Loewental, and W. L. Miller Homozygous Mutation G539R in the Gene for P450 Oxidoreductase in a Family Previously Diagnosed as Having 17,20-Lyase Deficiency J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3584 - 3588. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Tee, Q. Dong, and W. L. Miller Pathways Leading to Phosphorylation of P450c17 and to the Posttranslational Regulation of Androgen Biosynthesis Endocrinology, May 1, 2008; 149(5): 2667 - 2677. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Huang, V. Agrawal, K. M. Giacomini, and W. L. Miller Genetics of P450 oxidoreductase: Sequence variation in 842 individuals of four ethnicities and activities of 15 missense mutations PNAS, February 5, 2008; 105(5): 1733 - 1738. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Samandari, P. Kempna, J.-M. Nuoffer, G. Hofer, P. E Mullis, and C. E Fluck Human adrenal corticocarcinoma NCI-H295R cells produce more androgens than NCI-H295A cells and differ in 3{beta}-hydroxysteroid dehydrogenase type 2 and 17,20 lyase activities J. Endocrinol., December 1, 2007; 195(3): 459 - 472. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Mellon, S. R. Bair, C. Depoix, J.-L. Vigne, N. B. Hecht, and P. B. Brake Translin Coactivates Steroidogenic Factor-1-Stimulated Transcription Mol. Endocrinol., January 1, 2007; 21(1): 89 - 105. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Huang, A. Dardis, and W. L. Miller Regulation of Cytochrome b5 Gene Transcription by Sp3, GATA-6, and Steroidogenic Factor 1 in Human Adrenal NCI-H295A Cells Mol. Endocrinol., August 1, 2005; 19(8): 2020 - 2034. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. L. Miller Minireview: Regulation of Steroidogenesis by Electron Transfer Endocrinology, June 1, 2005; 146(6): 2544 - 2550. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Pandey and W. L. Miller Regulation of 17,20 Lyase Activity by Cytochrome b5 and by Serine Phosphorylation of P450c17 J. Biol. Chem., April 8, 2005; 280(14): 13265 - 13271. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-H. Yang and S. R Hammes Xenopus laevis CYP17 Regulates Androgen Biosynthesis Independent of the Cofactor Cytochrome b5 J. Biol. Chem., March 18, 2005; 280(11): 10196 - 10201. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Pattison, D. H. Abbott, W. Saltzman, A. D. Nguyen, G. Henderson, H. Jing, C. R. Pryce, A. J. Allen, A. J. Conley, and I. M. Bird Male Marmoset Monkeys Express an Adrenal Fetal Zone at Birth, But Not a Zona Reticularis in Adulthood Endocrinology, January 1, 2005; 146(1): 365 - 374. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Fluck and W. L. Miller GATA-4 and GATA-6 Modulate Tissue-Specific Transcription of the Human Gene for P450c17 by Direct Interaction with Sp1 Mol. Endocrinol., May 1, 2004; 18(5): 1144 - 1157. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. L. Miller Steroid 17{alpha}-Hydroxylase Deficiency--Not Rare Everywhere J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 40 - 42. [Full Text] [PDF] |
||||
![]() |
S. Vuocolo, E. Purev, D. Zhang, J. Bartek, K. Hansen, D. R. Soprano, and K. J. Soprano Protein Phosphatase 2A Associates with Rb2/p130 and Mediates Retinoic Acid-induced Growth Suppression of Ovarian Carcinoma Cells J. Biol. Chem., October 24, 2003; 278(43): 41881 - 41889. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Nowak, C.-Y. Pai, and V. G. Corces Protein Phosphatase 2A Activity Affects Histone H3 Phosphorylation and Transcription in Drosophila melanogaster Mol. Cell. Biol., September 1, 2003; 23(17): 6129 - 6138. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Fluck, W. L. Miller, and R. J. Auchus The 17, 20-Lyase Activity of Cytochrome P450c17 from Human Fetal Testis Favors the {Delta}5 Steroidogenic Pathway J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3762 - 3766. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Wood, V. L. Nelson, C. Ho, E. Jansen, C. Y. Wang, M. Urbanek, J. M. McAllister, S. Mosselman, and J. F. Strauss III The Molecular Phenotype of Polycystic Ovary Syndrome (PCOS) Theca Cells and New Candidate PCOS Genes Defined by Microarray Analysis J. Biol. Chem., July 11, 2003; 278(29): 26380 - 26390. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |